Terminated PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT01194609

A Pilot Study of Radiation-Immune Cell Combination Therapy in Cervical Cancer

A Pilot Study of Radiation-Immune Cell Combination Therapy in Recurrent or Persistent Cervical Cancer

Sponsor: Korea Cancer Center Hospital

Interventions Immune cell Low dose radiation

Updated 6 times since 2017 Last updated: May 7, 2014 Started: Sep 30, 2010 Primary completion: Sep 30, 2011 Completion: Apr 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

No further enrollment after two patients

Other terminated trials from Korea Cancer Center Hospital

More terminations from Korea Cancer Center Hospital

Other Uterine Cervical Neoplasms trials with similar outcome

Browse all Uterine Cervical Neoplasms trials

This PHASE1/PHASE2 trial investigates Uterine Cervical Neoplasms and is currently terminated or withdrawn. Korea Cancer Center Hospital leads this study, which shows 6 recorded versions since 2010 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Terminated PHASE1/PHASE2
Sep 2024 — Sep 2025 [monthly]

Terminated PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE1_PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Terminated PHASE1_PHASE2

First recorded

Sep 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Korea Cancer Center Hospital

Data source: Korea Cancer Center Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seoul, South Korea